Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Natalie McGauran"'
Autor:
Kirsten Janke, Corinna Kiefer, Natalie McGauran, Bernd Richter, Dietmar Krause, Beate Wieseler
Publikováno v:
BMC Rheumatology, Vol 6, Iss 1, Pp 1-11 (2022)
Abstract Background Some composite measures for determining the treatment effects of disease-modifying antirheumatic drugs on remission and low disease activity (LDA) in rheumatoid arthritis (RA) may produce misleading results if they include an acut
Externí odkaz:
https://doaj.org/article/8d3a8b91896c4fc7a2ac656fe9f3a0f5
Autor:
Susanne Haag, Lisa Junge, Fabian Lotz, Natalie McGauran, Marios Paulides, Regine Potthast, Thomas Kaiser
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 5, Iss 1, Pp 1-7 (2021)
Abstract Background Summaries of product characteristics (SmPCs) are regulatory documents published upon drug approval. They should report all relevant study data and advise how to use drugs safely and effectively. Patient-reported outcomes (PROs) ar
Externí odkaz:
https://doaj.org/article/4babb6daaf5b4fec8fedbdf05f72d72a
Autor:
Natalie McGauran, Beate Wieseler
Publikováno v:
Journal of European CME, Vol 10, Iss 1 (2021)
Externí odkaz:
https://doaj.org/article/b8a6860d279d4f028e1d01b4dd8ef0ec
Autor:
Wiebke Hoffmann-Eßer, Ulrich Siering, Edmund A. M. Neugebauer, Anne Catharina Brockhaus, Natalie McGauran, Michaela Eikermann
Publikováno v:
BMC Health Services Research, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background The AGREE II instrument is the most commonly used guideline appraisal tool. It includes 23 appraisal criteria (items) organized within six domains. AGREE II also includes two overall assessments (overall guideline quality, recomme
Externí odkaz:
https://doaj.org/article/3b92b24df7d74e64a0e1567c013a562f
Autor:
Regine Potthast, Volker Vervölgyi, Natalie McGauran, Michaela F Kerekes, Beate Wieseler, Thomas Kaiser
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e92067 (2014)
BACKGROUND: Clinical trial results registries may contain relevant unpublished information. Our main aim was to investigate the potential impact of the inclusion of reports from industry results registries on systematic reviews (SRs). METHODS: We ide
Externí odkaz:
https://doaj.org/article/b968a87a38ad4fcd9e3bc35fe8b363eb
Autor:
Beate Wieseler, Natalia Wolfram, Natalie McGauran, Michaela F Kerekes, Volker Vervölgyi, Petra Kohlepp, Marloes Kamphuis, Ulrich Grouven
Publikováno v:
PLoS Medicine, Vol 10, Iss 10, p e1001526 (2013)
BACKGROUND: Access to unpublished clinical study reports (CSRs) is currently being discussed as a means to allow unbiased evaluation of clinical research. The Institute for Quality and Efficiency in Health Care (IQWiG) routinely requests CSRs from ma
Externí odkaz:
https://doaj.org/article/884b8804a2294af1b1a6da222d102a3a
Publikováno v:
BMJ. :e072796
Autor:
Natalie McGauran, Beate Wieseler
Publikováno v:
BMJ Evidence-Based Medicine. 27:74-76
The availability of clinical trial records has increased markedly. This article outlines the challenges faced in information retrieval for evidence syntheses and provides a proposal for ensuring efficient and complete access to clinical trial records
Publikováno v:
BMJ (Clinical research ed.). 366
More than half of new drugs entering the German healthcare system have not been shown to add benefit. Beate Wieseler and colleagues argue that international drug development processes and policies are responsible and must be reformed
Autor:
Natalie McGauran, Beate Wieseler
A prerequisite for evidence-based medicine is the availability of complete and unbiased clinical trial information. Historically, journal publications have been the major route for disseminating the methods and results of clinical trials, and efforts
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62edc4d496c8704b314a3a8e17ae696f
https://europepmc.org/articles/PMC5289868/
https://europepmc.org/articles/PMC5289868/